Registered Nurse in Pennsauken, NJ Accepting Medicare

27 Registered Nurse nurses found. Showing 21 - 27

Christina Silvaria, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 7100 Airport Hwy, Pennsauken, NJ 08109 Phone: 856-324-5011    Fax: 856-317-5727

Ms. Melanie Jean Vignola, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave, Pennsauken, NJ 08109 Phone: 856-361-1100

Ms. Shana Elizabeth Careatti, RN Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave, Suite 300, Pennsauken, NJ 08109 Phone: 856-361-1133

Mrs. Stephanie F Betancourt, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2538 Starr Rd, Pennsauken, NJ 08109 Phone: 914-671-3027

Alva Thompson, Registered Nurse - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 2475 Mcclellan Ave, Pennsauken, NJ 08109 Phone: 856-675-3355

Mrs. Amma Nsuansa Avant, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave Ste 300, Pennsauken, NJ 08109 Phone: 347-525-7749

Mrs. Melanie Berthot, RN Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 2500 Mcclellan Ave, Pennsauken, NJ 08109 Phone: 856-203-0592

News Archive

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.

More research needed to determine link between folic acid and breast cancer

The daughters of rats who took folic acid supplements before conception, during pregnancy and while breast-feeding have breast cancer rates twice as high as other rats, according to a new study.

Echo Therapeutics declares reverse split of issued and outstanding common stock

Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013.

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)